Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1,800,000 Profiles
- More than 3,500 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Philipp le Coutre
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.8 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Disorders
Procedures
Anatomy
Concepts & Ideas
Physiology
Occupations
Phenomena
Sign-in to see full Profile
Network (preview)
15
Dörken, Bernd
15
Kreuzer, Karl-Anton
9
Baskaynak, Gökben
8
Gambacorti-Passerini, Carlo
7
Lupberger, Joachim
6
Na, Il-Kang
6
Schmidt, Christian
5
Schwarz, Michaela
5
Ottmann, Oliver
5
Ehninger, Gerhard
4
Arnold, Renate
4
Mologni, Luca
4
Marchesi, Edoardo
4
Massenkeil, Gero
4
Riess, Hanno
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Philipp le Coutre (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: le Coutre P; Meisel H; Hofmann J; Röcken C; Vuong G L; Neuburger S; Hemmati P G; Dörken B; Arnold R
Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation.
Gut 2009;58(5):699-702.
-
2008: Neuburger S; Massenkeil G; Seibold M; Lutz C; Tamm I; le Coutre P; Graf B; Doerken B; Arnold R
Successful salvage treatment of disseminated cutaneous fusariosis with liposomal amphotericin B and terbinafine after allogeneic stem cell transplantation.
Transplant infectious disease : an official journal of the Transplantation Society 2008;10(4):290-3.
-
2008: le Coutre Philipp; Ottmann Oliver G; Giles Francis; Kim Dong-Wook; Cortes Jorge; Gattermann Norbert; Apperley Jane F; Larson Richard A; Abruzzese Elisabetta; O'Brien Stephen G; Kuliczkowski Kazimierz; Hochhaus Andreas; Mahon Francois-Xavier; Saglio Giuseppe; Gobbi Marco; Kwong Yok-Lam; Baccarani Michele; Hughes Timothy; Martinelli Giovanni; Radich Jerald P; Zheng Ming; Shou Yaping; Kantarjian Hagop
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia.
Blood 2008;111(4):1834-9.
-
2007: Kantarjian Hagop M; Giles Francis; Gattermann Norbert; Bhalla Kapil; Alimena Giuliana; Palandri Francesca; Ossenkoppele Gert J; Nicolini Franck-Emmanuel; O'Brien Stephen G; Litzow Mark; Bhatia Ravi; Cervantes Francisco; Haque Ariful; Shou Yaping; Resta Debra J; Weitzman Aaron; Hochhaus Andreas; le Coutre Philipp
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance.
Blood 2007;110(10):3540-6.
-
2007: Westermann Jörg; Kopp Joachim; van Lessen Antje; Hecker Ann-Christine; Baskaynak Gökben; le Coutre Philipp; Döhner Konstanze; Döhner Hartmut; Dörken Bernd; Pezzutto Antonio
Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia.
British journal of haematology 2007;137(4):297-306.
-
2007: Hildebrandt Bert; le Coutre Philipp; Nicolaou Annett; Köble Konrad; Riess Hanno; Dörken Bernd
Cetuximab: appraisal of a novel drug against colorectal cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2007;176():135-43.
-
2006: Hildebrandt Bert; Rau Beate; Löffel Jürgen; Wust Peter; Nicolaou Annett; Gellermann Johanna; Le Coutre Philipp; Neuhaus Peter; Felix Roland; Wernecke Klaus-Dieter; Dörken Bernd; Riess Hanno
Adjuvant chemotherapy with folinic acid and 5-fluorouracil in patients with locally advanced rectal cancer previously treated by preoperative radiochemotherapy and curative tumor resection.
International journal of colorectal disease 2006;21(6):582-9.
-
2006: Westermann Jörg; Lessen Antje; Schlimper Claudia; Baskaynak Gökben; le Coutre Philipp; Dörken Bernd; Pezzutto Antonio
Simultaneous cytokine analysis by cytometric bead array for the detection of leukaemia-reactive T cells in patients with chronic myeloid leukaemia.
British journal of haematology 2006;132(1):32-5.
-
2005: Morawietz Lars; Kuhnen Cornelius; Katenkamp Detlef; Le Coutre Philipp; Ladhoff Axel; Petersen Iver
Unusual sarcomatoid neoplasm of the lung suggesting a myofibrosarcoma.
Virchows Archiv : an international journal of pathology 2005;447(6):990-5.
-
2005: Massenkeil G; Nagy M; Neuburger S; Tamm I; Lutz C; le Coutre P; Rosen O; Wernecke K-D; Dörken B; Arnold R
Survival after reduced-intensity conditioning is not inferior to standard high-dose conditioning before allogeneic haematopoietic cell transplantation in acute leukaemias.
Bone marrow transplantation 2005;36(8):683-9.
-
2005: Stelter L; le Coutre P; Stroszczynski C
[Peritoneal manifestation of plasmocytoma]
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 2005;177(4):580-1.
-
2005: Holdhoff Matthias; Kreuzer Karl-Anton; Appelt Christine; Scholz Regina; Na Il-Kang; Hildebrandt Bert; Riess Hanno; Jordan Andreas; Schmidt Christian A; Van Etten Richard A; Dörken Bernd; le Coutre Philipp
Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor.
Blood cells, molecules & diseases 2005;34(2):181-5.
-
2005: Na Il-Kang; Kreuzer Karl-Anton; Lupberger Joachim; Dörken Bernd; le Coutre Philipp
Quantitative RT-PCR of Wilms tumor gene transcripts (WT1) for the molecular monitoring of patients with accelerated phase bcr/abl + CML.
Leukemia research 2005;29(3):343-5.
-
2004: Kreuzer Karl-Anton; le Coutre Philipp
Re: Lange T et al. Quantitative reverse transcription polymerase chain reaction should not replace conventional cytogenetics for monitoring patients with chronic myeloid leukemia during early phase of imatinib therapy. Leukemia 2004; 89: 49-57.
Haematologica 2004;89(8):ELT12.
-
2004: le Coutre Philipp; Kreuzer Karl-Anton; Pursche Stefan; Bonin Malte v; Leopold Traugott; Baskaynak Gökben; Dörken Bernd; Ehninger Gerhard; Ottmann Oliver; Jenke Andreas; Bornhäuser Martin; Schleyer Eberhard
Pharmacokinetics and cellular uptake of imatinib and its main metabolite CGP74588.
Cancer chemotherapy and pharmacology 2004;53(4):313-23.
-
2004: Kreuzer Karl-Anton; Klühs Christine; Baskaynak Gökben; Movassaghi Kamran; Dörken Bernd; le Coutre Philipp
Filgrastim-induced stem cell mobilization in chronic myeloid leukaemia patients during imatinib therapy: safety, feasibility and evidence for an efficient in vivo purging.
British journal of haematology 2004;124(2):195-9.
-
2004: Schleyer E; Pursche S; Köhne C H; Schuler U; Renner U; Gschaidmeier H; Freiberg-Richter J; Leopold T; Jenke A; Bonin M; Bergemann T; le Coutre P; Gruner M; Bornhäuser M; Ottmann O G; Ehninger G
Liquid chromatographic method for detection and quantitation of STI-571 and its main metabolite N-desmethyl-STI in plasma, urine, cerebrospinal fluid, culture medium and cell preparations.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2004;799(1):23-36.
-
2004: Massenkeil Gero; Nagy Marion; Le Coutre Philipp; Heine Felicitas; Rosen Oliver; Dörken Berud; Arnold Renate
Nonmyeloablative stem cell transplantation in patients with ALL and AML results in low nonrelapse mortality despite high rate of infections and GVHD.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(5):395-402.
-
2004: Bornhäuser M; Illmer T; Le Coutre P; Pursche J; von Bonin M; Freiberg-Richter J; Schaich M; Platzbecker U; Thiede C; Ottmann O G; Köhne Ch; Braess J; Ehninger G; Schleyer E
Imatinib mesylate selectively influences the cellular metabolism of cytarabine in BCR/ABL negative leukemia cell lines and normal CD34+ progenitor cells.
Annals of hematology 2004;83 Suppl 1():S61-4.
-
2003: le Coutre P; Kreuzer K A; Massenkeil G; Baskaynak G; Zschieschang P; Genvresse I; Lupberger J; Mapara M; Dörken B; Arnold R
Autologous peripheral blood stem cell transplantation of stem cells harvested in imatinib-induced complete cytogenetic remission: an example of in vivo purging in CML.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(12):2525-6.
-
2003: Müller M C; Gattermann N; Lahaye T; Deininger M W N; Berndt A; Fruehauf S; Neubauer A; Fischer T; Hossfeld D K; Schneller F; Krause S W; Nerl C; Sayer H G; Ottmann O G; Waller C; Aulitzky W; le Coutre P; Freund M; Merx K; Paschka P; König H; Kreil S; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(12):2392-400.
-
2003: Kreuzer Karl-Anton; Klühs Christine; Schwarz Michaela; Dörken Bernd; Le Coutre Philipp
Safety and efficacy of stem cell mobilization under imatinib therapy.
Haematologica 2003;88(10):1199-200.
-
2003: Le Coutre Philipp; Kreuzer Karl-Anton; Na Il-Kang; Schwarz Michaela; Lupberger Joachim; Holdhoff Matthias; Baskaynak Gökben; Gschaidmeier Harald; Platzbecker Uwe; Ehninger Gerhard; Prejzner Witold; Huhn Dieter; Schmidt Christian A
Imatinib in Philadelphia chromosome-positive chronic phase CML patients: molecular and cytogenetic response rates and prediction of clinical outcome.
American journal of hematology 2003;73(4):249-55.
-
2003: Kreuzer K-A; Le Coutre P; Landt O; Na I-K; Schwarz M; Schultheis K; Hochhaus A; Dörken B
Preexistence and evolution of imatinib mesylate-resistant clones in chronic myelogenous leukemia detected by a PNA-based PCR clamping technique.
Annals of hematology 2003;82(5):284-9.
-
2003: Gunby Rosalind Helen; Cazzaniga Giovanni; Tassi Elena; Le Coutre Philipp; Pogliani Enrico; Specchia Giorgina; Biondi Andrea; Gambacorti-Passerini Carlo
Sensitivity to imatinib but low frequency of the TEL/PDGFRbeta fusion protein in chronic myelomonocytic leukemia.
Haematologica 2003;88(4):408-15.
-
2003: Baskaynak Gökben; Kreuzer Karl-Anton; Schwarz Michaela; Zuber Johannes; Audring Heike; Riess Hanno; Dörken Bernd; le Coutre Philipp
Squamous cutaneous epithelial cell carcinoma in two CML patients with progressive disease under imatinib treatment.
European journal of haematology 2003;70(4):231-4.
-
2002: Schwarz Michaela; Kreuzer Karl-Anton; Baskaynak Gökben; Dörken Bernd; le Coutre Philipp
Imatinib-induced acute generalized exanthematous pustulosis (AGEP) in two patients with chronic myeloid leukemia.
European journal of haematology 2002;69(4):254-6.
-
2002: Gambacorti-Passerini Carlo; le Coutre Philipp; Zucchetti Massimo; D'Incalci Maurizio
Binding of imatinib by alpha(1)-acid glycoprotein.
Blood 2002;100(1):367-8; author reply 368-9.
-
2002: Lupberger J; Kreuzer K A; Baskaynak G; Peters U R; le Coutre P; Schmidt C A
Quantitative analysis of beta-actin, beta-2-microglobulin and porphobilinogen deaminase mRNA and their comparison as control transcripts for RT-PCR.
Molecular and cellular probes 2002;16(1):25-30.
-
2002: le Coutre Philipp; Kreuzer Karl-Anton; Na Il-Kang; Lupberger Joachim; Holdhoff Matthias; Appelt Christine; Schwarz Michaela; Müller Christian; Gambacorti-Passerini Carlo; Platzbecker Uwe; Bonnet Ragnhild; Ehninger Gerhard; Schmidt Christian A
Determination of alpha-1 acid glycoprotein in patients with Ph+ chronic myeloid leukemia during the first 13 weeks of therapy with STI571.
Blood cells, molecules & diseases 2002;28(1):75-85.
-
2001: Kreuzer K A; Saborowski A; Lupberger J; Appelt C; Na I K; le Coutre P; Schmidt C A
Fluorescent 5'-exonuclease assay for the absolute quantification of Wilms' tumour gene (WT1) mRNA: implications for monitoring human leukaemias.
British journal of haematology 2001;114(2):313-8.
-
2001: Kreuzer K A; Bohn A; Lupberger J; Solassol J; le Coutre P; Schmidt C A
Simultaneous absolute quantification of target and control templates by real-time fluorescence reverse transcription-PCR using 4-(4'-dimethylaminophenylazo)benzoic acid as a dark quencher dye.
Clinical chemistry 2001;47(3):486-90.
-
2000: Gambacorti-Passerini C; Barni R; le Coutre P; Zucchetti M; Cabrita G; Cleris L; Rossi F; Gianazza E; Brueggen J; Cozens R; Pioltelli P; Pogliani E; Corneo G; Formelli F; D'Incalci M
Role of alpha1 acid glycoprotein in the in vivo resistance of human BCR-ABL(+) leukemic cells to the abl inhibitor STI571.
Journal of the National Cancer Institute 2000;92(20):1641-50.
-
2000: le Coutre P; Tassi E; Varella-Garcia M; Barni R; Mologni L; Cabrita G; Marchesi E; Supino R; Gambacorti-Passerini C
Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification.
Blood 2000;95(5):1758-66.
-
1999: le Coutre P; Mologni L; Cleris L; Marchesi E; Buchdunger E; Giardini R; Formelli F; Gambacorti-Passerini C
In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor.
Journal of the National Cancer Institute 1999;91(2):163-8.
-
1997: Gambacorti-Passerini C; le Coutre P; Mologni L; Fanelli M; Bertazzoli C; Marchesi E; Di Nicola M; Biondi A; Corneo G M; Belotti D; Pogliani E; Lydon N B
Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis.
Blood cells, molecules & diseases 1997;23(3):380-94.
-
1996: Gambacorti-Passerini C; Mologni L; Bertazzoli C; le Coutre P; Marchesi E; Grignani F; Nielsen P E
In vitro transcription and translation inhibition by anti-promyelocytic leukemia (PML)/retinoic acid receptor alpha and anti-PML peptide nucleic acid.
Blood 1996;88(4):1411-7.
Sign-in to see more
